Yahoo Finance21d
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
Jan. 7, 2025 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative disease program under their ongoing collaboration.
Mena FN21d
Capsida Announces Abbvie Opt-In For First Genetic Medicine Program From Neurodegenerative Disease Collaboration
Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative disease program under their ongoing collaboration. Capsida will receive a $ ...
FierceBiotech21d
AbbVie exercises first $40M option to advance Capsida-partnered CNS gene therapy
Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies after the Big Pharma exercised a $40 million option for the program.
Yahoo Finance21d
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
THOUSAND OAKS, Calif., Jan. 7, 2025 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative disease program under their ...
The Pharma Letter20d
AbbVie opts in for first genetic medicine program with Capsida
Capsida Biotherapeutics yesterday revealed US pharma major AbbVie (NYSE: ABBV) has exercised an option for the first neurodegenerative disease program under their ongoing collaboration. As a result, ...